Developing a specific NOTCH pathway inhibitor as a prostate cancer stem cell therapeutic (continuity)
Lead Participant:
ANASTASIS BIOTEC LIMITED
Abstract
no public description
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| ANASTASIS BIOTEC LIMITED | £40,280 | £ 40,280 |
Participant |
||
| DENTHERAPY LIMITED | ||
| INNOVATE UK |
People |
ORCID iD |
| Aga Epenetos (Project Manager) |